Copyright Reports & Markets. All rights reserved.

Global Nicotinamide Riboside(NR) Market Research Report 2021

Request for Sample of this report
Buy now

1 Nicotinamide Riboside(NR) Market Overview

  • 1.1 Product Overview and Scope of Nicotinamide Riboside(NR)
  • 1.2 Nicotinamide Riboside(NR) Segment by Type
    • 1.2.1 Global Nicotinamide Riboside(NR) Market Size Growth Rate Analysis by Type 2021 VS 2027
    • 1.2.2 Purity ≤98%
    • 1.2.3 Purity ＞98%
  • 1.3 Nicotinamide Riboside(NR) Segment by Application
    • 1.3.1 Global Nicotinamide Riboside(NR) Consumption Comparison by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Health Supplement
    • 1.3.3 Pharmaceutical Additives
  • 1.4 Global Market Growth Prospects
    • 1.4.1 Global Nicotinamide Riboside(NR) Revenue Estimates and Forecasts (2016-2027)
    • 1.4.2 Global Nicotinamide Riboside(NR) Production Capacity Estimates and Forecasts (2016-2027)
    • 1.4.3 Global Nicotinamide Riboside(NR) Production Estimates and Forecasts (2016-2027)
  • 1.5 Global Nicotinamide Riboside(NR) Market by Region
    • 1.5.1 Global Nicotinamide Riboside(NR) Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 2027
    • 1.5.2 North America Nicotinamide Riboside(NR) Estimates and Forecasts (2016-2027)
    • 1.5.3 Europe Nicotinamide Riboside(NR) Estimates and Forecasts (2016-2027)
    • 1.5.5 China Nicotinamide Riboside(NR) Estimates and Forecasts (2016-2027)
    • 1.5.5 Japan Nicotinamide Riboside(NR) Estimates and Forecasts (2016-2027)

2 Market Competition by Manufacturers

  • 2.1 Global Nicotinamide Riboside(NR) Production Capacity Market Share by Manufacturers (2016-2021)
  • 2.2 Global Nicotinamide Riboside(NR) Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Nicotinamide Riboside(NR) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.4 Global Nicotinamide Riboside(NR) Average Price by Manufacturers (2016-2021)
  • 2.5 Manufacturers Nicotinamide Riboside(NR) Production Sites, Area Served, Product Types
  • 2.6 Nicotinamide Riboside(NR) Market Competitive Situation and Trends
    • 2.6.1 Nicotinamide Riboside(NR) Market Concentration Rate
    • 2.6.2 Global 5 and 10 Largest Nicotinamide Riboside(NR) Players Market Share by Revenue
    • 2.6.3 Mergers & Acquisitions, Expansion

3 Production and Capacity by Region

  • 3.1 Global Production Capacity of Nicotinamide Riboside(NR) Market Share by Region (2016-2021)
  • 3.2 Global Nicotinamide Riboside(NR) Revenue Market Share by Region (2016-2021)
  • 3.3 Global Nicotinamide Riboside(NR) Production, Revenue, Price and Gross Margin (2016-2021)
  • 3.4 North America Nicotinamide Riboside(NR) Production
    • 3.4.1 North America Nicotinamide Riboside(NR) Production Growth Rate (2016-2021)
    • 3.4.2 North America Nicotinamide Riboside(NR) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.5 Europe Nicotinamide Riboside(NR) Production
    • 3.5.1 Europe Nicotinamide Riboside(NR) Production Growth Rate (2016-2021)
    • 3.5.2 Europe Nicotinamide Riboside(NR) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.6 China Nicotinamide Riboside(NR) Production
    • 3.6.1 China Nicotinamide Riboside(NR) Production Growth Rate (2016-2021)
    • 3.6.2 China Nicotinamide Riboside(NR) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.7 Japan Nicotinamide Riboside(NR) Production
    • 3.7.1 Japan Nicotinamide Riboside(NR) Production Growth Rate (2016-2021)
    • 3.7.2 Japan Nicotinamide Riboside(NR) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Nicotinamide Riboside(NR) Consumption by Region

  • 4.1 Global Nicotinamide Riboside(NR) Consumption by Region
    • 4.1.1 Global Nicotinamide Riboside(NR) Consumption by Region
    • 4.1.2 Global Nicotinamide Riboside(NR) Consumption Market Share by Region
  • 4.2 North America
    • 4.2.1 North America Nicotinamide Riboside(NR) Consumption by Country
    • 4.2.2 U.S.
    • 4.2.3 Canada
  • 4.3 Europe
    • 4.3.1 Europe Nicotinamide Riboside(NR) Consumption by Country
    • 4.3.2 Germany
    • 4.3.3 France
    • 4.3.4 U.K.
    • 4.3.5 Italy
    • 4.3.6 Russia
  • 4.4 Asia Pacific
    • 4.4.1 Asia Pacific Nicotinamide Riboside(NR) Consumption by Region
    • 4.4.2 China
    • 4.4.3 Japan
    • 4.4.4 South Korea
    • 4.4.5 Taiwan
    • 4.4.6 Southeast Asia
    • 4.4.7 India
    • 4.4.8 Australia
  • 4.5 Latin America
    • 4.5.1 Latin America Nicotinamide Riboside(NR) Consumption by Country
    • 4.5.2 Mexico
    • 4.5.3 Brazil

5 Production, Revenue, Price Trend by Type

  • 5.1 Global Nicotinamide Riboside(NR) Production Market Share by Type (2016-2021)
  • 5.2 Global Nicotinamide Riboside(NR) Revenue Market Share by Type (2016-2021)
  • 5.3 Global Nicotinamide Riboside(NR) Price by Type (2016-2021)

6 Consumption Analysis by Application

  • 6.1 Global Nicotinamide Riboside(NR) Consumption Market Share by Application (2016-2021)
  • 6.2 Global Nicotinamide Riboside(NR) Consumption Growth Rate by Application (2016-2021)

7 Key Companies Profiled

  • 7.1 Tru Niagen
    • 7.1.1 Tru Niagen Nicotinamide Riboside(NR) Corporation Information
    • 7.1.2 Tru Niagen Nicotinamide Riboside(NR) Product Portfolio
    • 7.1.3 Tru Niagen Nicotinamide Riboside(NR) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.1.4 Tru Niagen Main Business and Markets Served
    • 7.1.5 Tru Niagen Recent Developments/Updates
  • 7.2 Bio Fu
    • 7.2.1 Bio Fu Nicotinamide Riboside(NR) Corporation Information
    • 7.2.2 Bio Fu Nicotinamide Riboside(NR) Product Portfolio
    • 7.2.3 Bio Fu Nicotinamide Riboside(NR) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.2.4 Bio Fu Main Business and Markets Served
    • 7.2.5 Bio Fu Recent Developments/Updates
  • 7.3 Myland Pharm and Nutrition
    • 7.3.1 Myland Pharm and Nutrition Nicotinamide Riboside(NR) Corporation Information
    • 7.3.2 Myland Pharm and Nutrition Nicotinamide Riboside(NR) Product Portfolio
    • 7.3.3 Myland Pharm and Nutrition Nicotinamide Riboside(NR) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.3.4 Myland Pharm and Nutrition Main Business and Markets Served
    • 7.3.5 Myland Pharm and Nutrition Recent Developments/Updates
  • 7.4 Genex Formulas
    • 7.4.1 Genex Formulas Nicotinamide Riboside(NR) Corporation Information
    • 7.4.2 Genex Formulas Nicotinamide Riboside(NR) Product Portfolio
    • 7.4.3 Genex Formulas Nicotinamide Riboside(NR) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.4.4 Genex Formulas Main Business and Markets Served
    • 7.4.5 Genex Formulas Recent Developments/Updates
  • 7.5 Shinkowa Pharmaceutical
    • 7.5.1 Shinkowa Pharmaceutical Nicotinamide Riboside(NR) Corporation Information
    • 7.5.2 Shinkowa Pharmaceutical Nicotinamide Riboside(NR) Product Portfolio
    • 7.5.3 Shinkowa Pharmaceutical Nicotinamide Riboside(NR) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.5.4 Shinkowa Pharmaceutical Main Business and Markets Served
    • 7.5.5 Shinkowa Pharmaceutical Recent Developments/Updates
  • 7.6 Bontac
    • 7.6.1 Bontac Nicotinamide Riboside(NR) Corporation Information
    • 7.6.2 Bontac Nicotinamide Riboside(NR) Product Portfolio
    • 7.6.3 Bontac Nicotinamide Riboside(NR) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.6.4 Bontac Main Business and Markets Served
    • 7.6.5 Bontac Recent Developments/Updates
  • 7.7 Longer Livetech
    • 7.7.1 Longer Livetech Nicotinamide Riboside(NR) Corporation Information
    • 7.7.2 Longer Livetech Nicotinamide Riboside(NR) Product Portfolio
    • 7.7.3 Longer Livetech Nicotinamide Riboside(NR) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.7.4 Longer Livetech Main Business and Markets Served
    • 7.7.5 Longer Livetech Recent Developments/Updates

8 Nicotinamide Riboside(NR) Manufacturing Cost Analysis

  • 8.1 Nicotinamide Riboside(NR) Key Raw Materials Analysis
    • 8.1.1 Key Raw Materials
    • 8.1.2 Key Raw Materials Price Trend
    • 8.1.3 Key Suppliers of Raw Materials
  • 8.2 Proportion of Manufacturing Cost Structure
  • 8.3 Manufacturing Process Analysis of Nicotinamide Riboside(NR)
  • 8.4 Nicotinamide Riboside(NR) Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

  • 9.1 Marketing Channel
  • 9.2 Nicotinamide Riboside(NR) Distributors List
  • 9.3 Nicotinamide Riboside(NR) Customers

10 Market Dynamics

  • 10.1 Nicotinamide Riboside(NR) Industry Trends
  • 10.2 Nicotinamide Riboside(NR) Growth Drivers
  • 10.3 Nicotinamide Riboside(NR) Market Challenges
  • 10.4 Nicotinamide Riboside(NR) Market Restraints

11 Production and Supply Forecast

  • 11.1 Global Forecasted Production of Nicotinamide Riboside(NR) by Region (2022-2027)
  • 11.2 North America Nicotinamide Riboside(NR) Production, Revenue Forecast (2022-2027)
  • 11.3 Europe Nicotinamide Riboside(NR) Production, Revenue Forecast (2022-2027)
  • 11.4 China Nicotinamide Riboside(NR) Production, Revenue Forecast (2022-2027)
  • 11.5 Japan Nicotinamide Riboside(NR) Production, Revenue Forecast (2022-2027)

12 Consumption and Demand Forecast

  • 12.1 Global Forecasted Demand Analysis of Nicotinamide Riboside(NR)
  • 12.2 North America Forecasted Consumption of Nicotinamide Riboside(NR) by Country
  • 12.3 Europe Market Forecasted Consumption of Nicotinamide Riboside(NR) by Country
  • 12.4 Asia Pacific Market Forecasted Consumption of Nicotinamide Riboside(NR) by Region
  • 12.5 Latin America Forecasted Consumption of Nicotinamide Riboside(NR) by Country

13 Forecast by Type and by Application (2022-2027)

  • 13.1 Global Production, Revenue and Price Forecast by Type (2022-2027)
    • 13.1.1 Global Forecasted Production of Nicotinamide Riboside(NR) by Type (2022-2027)
    • 13.1.2 Global Forecasted Revenue of Nicotinamide Riboside(NR) by Type (2022-2027)
    • 13.1.3 Global Forecasted Price of Nicotinamide Riboside(NR) by Type (2022-2027)
  • 13.2 Global Forecasted Consumption of Nicotinamide Riboside(NR) by Application (2022-2027)

14 Research Finding and Conclusion

    15 Methodology and Data Source

    • 15.1 Methodology/Research Approach
      • 15.1.1 Research Programs/Design
      • 15.1.2 Market Size Estimation
      • 15.1.3 Market Breakdown and Data Triangulation
    • 15.2 Data Source
      • 15.2.1 Secondary Sources
      • 15.2.2 Primary Sources
    • 15.3 Author List

    The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027. by Application segment also provides consumption during the forecast period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Purity ≤98%
    Purity ＞98%

    Segment by Application
    Health Supplement
    Pharmaceutical Additives

    By Company
    Tru Niagen
    Bio Fu
    Myland Pharm and Nutrition
    Genex Formulas
    Shinkowa Pharmaceutical
    Bontac
    Longer Livetech

    Production by Region
    North America
    Europe
    China
    Japan

    Consumption by Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    Buy now